NCT06974812 2026-01-29
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Recruiting
Clinical Trials
1 trialsRecruiting × Unresectable Locally Advanced or Metastatic Solid Tumors × Other solid neoplasm × Clear all